JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
PRLD - Prelude Therapeutics Inc.
USD | NASDAQ | Healthcare
Summary
Summary PRLD Stock
Financials
Financials PRLD Stock
Loading...
Loading...
Income Statement
Income Statement PRLD Stock
Balance Sheet
Balance Sheet PRLD Stock
Cash Flow Statement
Cash Flow Statement PRLD Stock
Loading...
Loading...
Home
Stocks
Prelude Therapeutics Inc. (PRLD)
Financials
Financials of PRLD
Loading...
Loading...
PRLD Financials - Prelude Therapeutics Income & Cash Flow | Ledgeburg
Loading...
Loading...
Revenue
$12.14M
Operating Income
$-104.566M
Net Income
$-99.498M
Share Count (Basic)
76.956194M
Operating Cash Flow
$-56.302M
Free Cash Flow
$-56.369M
Cash And Short-Term Equivalents
$103.214M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
5M
10M
FY2024
FY2025
Revenue $USD
0
2M
4M
6M
Q1 FY25
Q3 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-120M
-110M
-100M
FY2021
Annual
Quarterly
Margins
Gross
Operating
Net
-2000%
-1800%
-1600%
-1400%
-1200%
-1000%
-800%
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-30M
-25M
-20M
-15M
-10M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-320%
-300%
-280%
-260%
-240%
-220%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26